A PEGylated hyaluronic acid conjugate for targeted cancer immunotherapy

Jung Min Shin; Se Jin Oh; Seunglee Kwon; V. G. Deepagan; Minchang Lee; Seok Ho Song; Hyo‐Jung Lee; Suyeon Kim; Kwon‐Ho Song; Tae Woo Kim; Jae Hyung Park

doi:10.1016/j.jconrel.2017.08.032

JOURNAL ARTICLE

A PEGylated hyaluronic acid conjugate for targeted cancer immunotherapy

Jung Min Shin Se Jin Oh Seunglee Kwon V. G. Deepagan Minchang Lee Seok Ho Song Hyo‐Jung Lee Suyeon Kim Kwon‐Ho Song Tae Woo Kim Jae Hyung Park

Year: 2017 Journal: Journal of Controlled Release Vol: 267 Pages: 181-190 Publisher: Elsevier BV

DOI: 10.1016/j.jconrel.2017.08.032

Get Full-Text PDF Get Analytical Report

Keywords:

CTL* Cytotoxic T cell Cancer immunotherapy Conjugate Hyaluronic acid Cancer research Chemistry Antigen Tumor microenvironment Immunotherapy Immunology Biology In vitro Biochemistry Immune system Tumor cells

Metrics

Cited By

2.79

FWCI (Field Weighted Citation Impact)

Refs

0.88

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Immunotherapy and Immune Responses

Life Sciences → Immunology and Microbiology → Immunology

Peptidase Inhibition and Analysis

Health Sciences → Medicine → Oncology

RNA Interference and Gene Delivery

Life Sciences → Biochemistry, Genetics and Molecular Biology → Molecular Biology

A PEGylated hyaluronic acid conjugate for targeted cancer immunotherapy

Metrics

Citation History

Topics

Related Documents

PD-L1 siRNA–hyaluronic acid conjugate for dual-targeted cancer immunotherapy

Hyaluronic acid-serum albumin conjugate-based nanoparticles for targeted cancer therapy

Hyaluronic Acid Derivatives for Targeted Cancer Therapy

523P AFP-maytansine conjugate: A novel targeted cancer immunotherapy

A hyaluronic acid–methotrexate conjugate for targeted therapy of rheumatoid arthritis